Clinical trial · Interventional
Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve in Oropharyngeal Cancer Pain
Standard Pulsed Radiofrequency Versus Supervoltage Pulsed Radiofrequency Glossopharyngeal Nerve Therapy in Management of Oropharyngeal Cancer Pain: Randomized Clinical Trial.
NCT06121102CI-TRIAL-00071294unknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The aim of this study is to evaluate the safety and efficacy of supervoltage pulsed radiofrequency glossopharyngeal nerve therapy versus standard pulsed radiofrequency in reduction of oropharyngeal cancer pain, through Visual analog scale score reduction.
Conditions
Conditions (5)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Glossopharyngeal Nerve | — | UNRESOLVED | — |
| Oropharyngeal Cancer | Malignant Oropharyngeal Neoplasm | CURATED_EXACT | 0.92 |
| Pain | — | UNRESOLVED | — |
| Pulsed Radiofrequency | — | UNRESOLVED | — |
| Super Voltage Pulsed Radiofrequency | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Standard voltage pulsed radiofrequency glossopharyngeal nerve block | Procedure | — | UNRESOLVED |
| Supervoltage pulsed radiofrequency glossopharyngeal nerve block | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Group A (supervoltage pulsed radiofrequency glossopharyngeal nerve block)
- description
- Patients will receive supervoltage pulsed radiofrequency glossopharyngeal nerve block.
- interventionNames
- Procedure: Supervoltage pulsed radiofrequency glossopharyngeal nerve block
- type
- ACTIVE_COMPARATOR
- label
- Group B (standard voltage pulsed radiofrequency glossopharyngeal nerve block)
- description
- Patients will receive standard voltage pulsed radiofrequency glossopharyngeal nerve block.
- interventionNames
- Procedure: Standard voltage pulsed radiofrequency glossopharyngeal nerve block
Primary outcomes (1)
- measure
- The degree of pain
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 70 Years
Show eligibility criteria text
Inclusion Criteria: * Age ≥ 18 and ≤ 70 Years. * Both sexes * American Society of Anesthesiologists (ASA) class II and III. * Patients under pain management for oropharyngeal cancer (failed medical treatment or intolerance to the side effects of the drug). * Visual analog scale (VAS) equal to or more than 6 cm in spite medical treatment. Exclusion Criteria: * Patient refusal. * Patients with local or systemic sepsis. * Uncorrectable coagulopathy. * Unstable cardiovascular disease. * History of psychiatric and cognitive disorders. * Patients allergic to medication used.7 * Unable to lie supine. * Local anatomical distortion (either congenital, post-surgical or post-radiotherapy) making intervention difficult and hazardous. * Elongated styloid process \> 25 mm. * Age less than 18 year and more than 70 year.
References
Publications (0)
Data not yet available
No reference posted for this study.